122 related articles for article (PubMed ID: 7878477)
21. Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.
Hayashi T; Hideshima T; Nguyen AN; Munoz O; Podar K; Hamasaki M; Ishitsuka K; Yasui H; Richardson P; Chakravarty S; Murphy A; Chauhan D; Higgins LS; Anderson KC
Clin Cancer Res; 2004 Nov; 10(22):7540-6. PubMed ID: 15569984
[TBL] [Abstract][Full Text] [Related]
22. [Cell division mechanism of multiple myeloma].
Shimizu S
Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1055-60. PubMed ID: 7561358
[No Abstract] [Full Text] [Related]
23. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma.
Ribatti D; Nico B; Vacca A
Oncogene; 2006 Jul; 25(31):4257-66. PubMed ID: 16518413
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of interleukin-6 gene expression in the bone marrow of patients with multiple myeloma.
Iwasaki T; Hamano T; Ogata A; Kakishita E
Int J Hematol; 1999 Oct; 70(3):163-8. PubMed ID: 10561908
[TBL] [Abstract][Full Text] [Related]
25. The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma.
Barillé S; Bataille R; Amiot M
Eur Cytokine Netw; 2000 Dec; 11(4):546-51. PubMed ID: 11125296
[TBL] [Abstract][Full Text] [Related]
26. Multiple myeloma: increasing evidence for a multistep transformation process.
Hallek M; Bergsagel PL; Anderson KC
Blood; 1998 Jan; 91(1):3-21. PubMed ID: 9414264
[TBL] [Abstract][Full Text] [Related]
27. Role of interleukin-6 in multiple myeloma.
Bataille R; Klein B
Ann Med Interne (Paris); 1992; 143 Suppl 1():77-9. PubMed ID: 1300892
[No Abstract] [Full Text] [Related]
28. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
Yamashita K; Iwasaki T; Tsujimura T; Sugihara A; Yamada N; Ueda H; Okamura H; Futani H; Maruo S; Terada N
Oncol Rep; 2002; 9(6):1237-44. PubMed ID: 12375027
[TBL] [Abstract][Full Text] [Related]
29. Accelerated proliferation of myeloma cells by interleukin-6 cooperating with fibroblast growth factor receptor 3-mediated signals.
Ishikawa H; Tsuyama N; Liu S; Abroun S; Li FJ; Otsuyama K; Zheng X; Ma Z; Maki Y; Iqbal MS; Obata M; Kawano MM
Oncogene; 2005 Sep; 24(41):6328-32. PubMed ID: 15940250
[TBL] [Abstract][Full Text] [Related]
30. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
[TBL] [Abstract][Full Text] [Related]
31. Targeting the vascular endothelial growth factor pathway in the treatment of multiple myeloma.
Podar K; Richardson PG; Chauhan D; Anderson KC
Expert Rev Anticancer Ther; 2007 Apr; 7(4):551-66. PubMed ID: 17428175
[TBL] [Abstract][Full Text] [Related]
32. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
33. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
34. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein.
Gimble JM; Wanker F; Wang CS; Bass H; Wu X; Kelly K; Yancopoulos GD; Hill MR
J Cell Biochem; 1994 Jan; 54(1):122-33. PubMed ID: 8126083
[TBL] [Abstract][Full Text] [Related]
35. A ciliary neurotrophic factor-sensitive human myeloma cell line.
Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
[TBL] [Abstract][Full Text] [Related]
36. Homing mechanisms in the biology of multiple myeloma.
Van Camp B; Van Riet I
Verh K Acad Geneeskd Belg; 1998; 60(3):163-94. PubMed ID: 9803879
[TBL] [Abstract][Full Text] [Related]
37. Multiple myeloma--recent developments in molecular and cellular biology.
Barlogie B; Hoover R; Epstein J
Curr Top Microbiol Immunol; 1995; 194():37-41. PubMed ID: 7895511
[No Abstract] [Full Text] [Related]
38. [Cytokines involved in plasma cell proliferative disorders].
Kawano M
Rinsho Ketsueki; 1992 Aug; 33(8):999-1011. PubMed ID: 1404868
[No Abstract] [Full Text] [Related]
39. Multiple cytokine-producing plasmablastic solitary plasmacytoma of bone expressing multiple cytokine receptors.
Nakayama S; Yokote T; Iwaki K; Hirata Y; Takayama A; Akioka T; Miyoshi T; Nishiwaki U; Masuda Y; Tsuji M; Hanafusa T
Leuk Lymphoma; 2013 Apr; 54(4):871-3. PubMed ID: 22971174
[No Abstract] [Full Text] [Related]
40. Mechanisms of the escape phase of myeloma.
Joshua DE; Gibson J; Brown RD
Blood Rev; 1994 Mar; 8(1):13-20. PubMed ID: 8205006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
